CNVVY (ConvaTec Group) Net Income From Continuing Operations : $191 Mil (TTM As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is ConvaTec Group Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. ConvaTec Group's net income from continuing operations for the six months ended in Dec. 2024 was $112 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Dec. 2024 was $191 Mil.

ConvaTec Group Net Income From Continuing Operations Historical Data

The historical data trend for ConvaTec Group's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ConvaTec Group Net Income From Continuing Operations Chart

ConvaTec Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Income From Continuing Operations

Get a 7-Day Free Trial

112.50

117.60

62.90

130.30

190.50

ConvaTec Group Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Net Income From Continuing Operations	Get a 7-Day Free Trial															14.60	55.70	74.60	78.60	111.90

ConvaTec Group Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $191 Mil.

ConvaTec Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ConvaTec Group PLC (OTCPK:CNVVY) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

CNVVF:USA CTEC1N:Mexico CTECl:UK CTEC:UK 2CV:Germany

Address

20 Eastbourne Terrace, 7th Floor, Paddington, London, GBR, W2 6LG

Website

https://www.convatecgroup.com

Originally spun out of Bristol-Myers Squibb, ConvaTec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 33% and 28% of total revenue, respectively. Continence care has become a slightly smaller business (21% of revenue) following the decision to exit the acute care market, and infusion sets contribute 18% of consolidated revenue.